Rebecca Graff

Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.

Deng Z, Hajihosseini M, Moore JX, Khan S, Graff RE, Bondy ML, Chung BI, Langston ME.

Cancer Epidemiol Biomarkers Prev. 2023 11 01. 32(11):1651-1659. PMID: 37624040

Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial.

Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM.

Eur Urol Oncol. 2023 Oct 29. PMID: 37907387

Association of cancer history with structural brain aging markers of Alzheimer's disease and related dementias risk.

Wang J, Sims KD, Ackley SF, Chen R, Kobayashi LC, Hayes-Larson E, Mayeda ER, Buto P, Zimmerman SC, Graff RE, Glymour MM.

Alzheimers Dement. 2023 Oct 09. PMID: 37811979

Association between cancer and dementia risk in the UK Biobank: evidence of diagnostic bias.

Wang J, Buto P, Ackley SF, Kobayashi LC, Graff RE, Zimmerman SC, Hayes-Larson E, Mayeda ER, Asiimwe SB, Calmasini C, Glymour MM.

Eur J Epidemiol. 2023 Oct. 38(10):1069-1079. PMID: 37634228

Diabetes and incidence of breast cancer and its molecular subtypes: A systematic review and meta-analysis.

Xiong F, Dai Q, Zhang S, Bent S, Tahir P, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Graff RE.

Diabetes Metab Res Rev. 2023 Aug 07. e3709. PMID: 37545374

Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes.

Michalek IM, Graff RE, Sanchez A, Choueiri TK, Cho E, Preston MA, Wilson KM.

Acta Oncol. 2023 Sep. 62(9):988-993. PMID: 37482537

Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study.

Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Huang CY, Graff RE.

Br J Cancer. 2023 09. 129(4):648-655. PMID: 37402868

Genetically adjusted PSA levels for prostate cancer screening.

Kachuri L, Hoffmann TJ, Jiang Y, Berndt SI, Shelley JP, Schaffer KR, Machiela MJ, Freedman ND, Huang WY, Li SA, Easterlin R, Goodman PJ, Till C, Thompson I, Lilja H, Van Den Eeden SK, Chanock SJ, Haiman CA, Conti DV, Klein RJ, Mosley JD, Graff RE, Witte JS.

Nat Med. 2023 Jun. 29(6):1412-1423. PMID: 37264206

Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.

Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM.

Br J Cancer. 2023 08. 129(2):346-355. PMID: 37217583

Education, incident cancer, and rate of memory decline in a national sample of US adults in mid-to-later-life.

Ospina-Romero M, Brenowitz WD, Glymour MM, Westrick A, Graff RE, Hayes-Larson E, Mayeda ER, Ackley SF, Kobayashi LC.

J Geriatr Oncol. 2023 06. 14(5):101530. PMID: 37210786